Kermanshah University of Medical Sciences
Iran
Clinical Trials
553
Active:0
Completed:226
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:18
Phase 2:136
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (553 trials with phase data)• Click on a phase to view related trials
Not Applicable
287 (51.9%)Phase 2
136 (24.6%)Phase 3
108 (19.5%)Phase 1
18 (3.3%)Phase 4
3 (0.5%)Early Phase 1
1 (0.2%)Colchicine Plus Phenolic Monoterpenes to Treat COVID-19
Phase 1
Completed
- Conditions
- COVID-19
- Interventions
- Drug: Standard Treatment
- First Posted Date
- 2020-05-18
- Last Posted Date
- 2021-04-20
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Target Recruit Count
- 120
- Registration Number
- NCT04392141
- Locations
- 🇮🇷
Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran, Kermanshah, Iran, Islamic Republic of
Application of Desferal to Treat COVID-19
- First Posted Date
- 2020-04-03
- Last Posted Date
- 2020-05-04
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Target Recruit Count
- 50
- Registration Number
- NCT04333550
- Locations
- 🇮🇷
Regenerative Medicine Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran, Kermanshah, Iran, Islamic Republic of
News
No news found